Advertisement

Jaundice pp 329-349 | Cite as

Causation and Consequences of Cholestasis: An Overview

  • Fenton Schaffner
  • Hans Popper
Part of the Hepatology book series (H, volume 2)

Abstract

“Intrahepatic cholestasis” was coined in 1952 to describe the morphologic findings in the liver when clinical and laboratory features pointed to biliary obstruction and none was found (1). That the condition could be caused by drugs was recognized more than a decade earlier (2). It was originally called intrahepatic obstructive jaundice and many proposals have been made about the mechanism by which the phenomenon is produced.

Keywords

Bile Acid Bile Salt Primary Biliary Cirrhosis Biliary Atresia Biliary Obstruction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    POPPER H, SCHAFFNER F: Laboratory diagnosis of liver disease. Coordinated use of histological and biochemical observations. JAMA 150: 1367–1372, 1952.CrossRefGoogle Scholar
  2. 2.
    HANGER FM, GUTMAN AB: Postarsphenamine jaundice apparently due to obstruction of intrahepatic biliary tract. JAMA 115: 263–271, 1940.CrossRefGoogle Scholar
  3. 3.
    RÖSSLE R: Die cholangiolitische Zirrhose. In Entzütndungen der Leber, vol. 5, no. 1, of Handbuch der speziellen pathologischen Anatomie und Histologie. Ed. F Henke, O Lubarsch. Berlin, Springer, 1939, pp 448–452.Google Scholar
  4. 4.
    WATSON CJ, HOFFBAUER FW: Problem of prolonged hepatitis with particular reference to cholangiolitic type and to development of cholangiolitic cirrhosis of liver. Ann Intern Med 25: 195–227, 1946.PubMedGoogle Scholar
  5. 5.
    POPPER H, SZATO PB: Intrahepatic cholestasis (“cholangio-litis”). Gastroenterology 31: 683–699, 1956.PubMedGoogle Scholar
  6. 6.
    WACHSTEIN M, MEISEL E: Histochemistry of hepatic phosphatase at a physiologic pH. With special reference to the demonstration of bile canaliculi. Am J Clin Pathol 27: 13–23, 1957.PubMedGoogle Scholar
  7. 7.
    ROUILLER C: Les canalicules biliares. Etude au microscope electronique. Acta Anat (Basel) 26: 94–109, 1956.CrossRefGoogle Scholar
  8. 8.
    SCHAFFNER F, POPPER H: Morphologic studies of cholestasis. Gastroenterology 37: 565–573, 1959.PubMedGoogle Scholar
  9. 9.
    STEINER JW, JEZEQUEL AM, PHILLIPS MJ, et al: Some aspects of the ultrastructural pathology of the liver. In Progress in Liver Diseases, vol. 2. Ed. H. Popper, F. Schaffner. New York, Grune and Stratton, 1965. pp. 303–372.Google Scholar
  10. 10.
    ZAKI FG: Ultrastructure of hepatic cholestasis. Medicine 45: 537–545, 1966.PubMedCrossRefGoogle Scholar
  11. 11.
    SCHATZKI P: The passage of radioactive lanthanum from the biliary to the vascular system. An electron microscopic and radioactive tracer study. Z Zellforsch 119: 451–459, 1971.PubMedCrossRefGoogle Scholar
  12. 12.
    DEWOLF-PEEERS C, DEVOS R, DESMET V: Histochemical evidence of a cholestatic period in neonatal rats. Pediatr Res 5: 704–709, 1971.CrossRefGoogle Scholar
  13. 13.
    TOULOUKIAN RJ, DOWNING SE: Cholestasis associated with long-term parenteral hyperalimentation. Arch Surg 106: 58–62, 1973.PubMedCrossRefGoogle Scholar
  14. 14.
    LEVINE G, FAVARA BE, MIERAU G, BAILEY WC: Jaundice, liver ultrastructure, and congenital pyloric stenosis. Arch Pathol 95: 267–270, 1973.PubMedGoogle Scholar
  15. 15.
    RAGER R, FINEGOLD MJ: Cholestasis in low birth weight prematures: is parenteral alimentation the cause? Am J Pathol 74: 6a–7a, 1974.Google Scholar
  16. 16.
    WILLS EJ, EPSTEIN ME: Subcellular changes in surface adenosine triphosphatase activity of human liver in extrahepatic obstructive jaundice. Am J Pathol 49605–635, 1966.PubMedGoogle Scholar
  17. 17.
    DESMET VJ: Morphologic and histochemical aspects of cholestasis. In Progress in Liver Diseases, vol. 4. Ed. H. Popper, F. Schaffner. New York, Grune and Stratton, 1972. pp. 97–132.Google Scholar
  18. 18.
    STEINER JW, CARRUTHERS JS: Studies on the fine structure of the terminal branches of the biliary tree. II. Observations of pathologically altered bile canaliculi. Am J Pathol 39 41–63, 1961.PubMedGoogle Scholar
  19. 19.
    HAMPTON JC: Electron microscopic study of extrahepatic biliary obstruction in the mouse. Lab Invest 10: 502–513, 1961.PubMedGoogle Scholar
  20. 20.
    POPPER H: Cholestasis. Ann Rev Med 19: 39–56, 1968.PubMedCrossRefGoogle Scholar
  21. 21.
    DUBIN IN, PETERSON LH: An explanation for the centrolobular localization of intrahepatic bile stasis in acute liver diseases. Am J Med Sci 236: 45–52, 1958.PubMedCrossRefGoogle Scholar
  22. 22.
    SCHAFFNER F, KNIFEEN JC: Electron microscopy as related to hepatotoxicity. Ann NY Acad Sci 104: 847–857, 1963.Google Scholar
  23. 23.
    SCHAFFNER F, JAVITT NB: Morphologic changes in hamster liver during intrahepatic cholestasis induced by taurolithocholate. Lab Invest 15: 1783–1792, 1966.PubMedGoogle Scholar
  24. 24.
    JAVITT NB, EMERMAN S: Effect of sodium tarolithocholate on bile flow and bile acid excretion. J Clin Invest 47: 1002–1014, 1968.PubMedCrossRefGoogle Scholar
  25. 25.
    HUTTRER F, KLION FM, WENGRAF A, et al: Hepatocellular adaptation and injury. Structural and biochemical changes following dieldrin and methyl butter yellow. Lab Invest 20: 455–464, 1969.Google Scholar
  26. 26.
    BOYD GS, PERCY-ROBB IW: Enzymatic regulation of bile acid synthesis. Am J Med 51: 580–587, 1971.PubMedCrossRefGoogle Scholar
  27. 27.
    SCHAFFNER F, POPPER H: Hypothesis: cholestasis is the result of hypoactive hypertrophic smooth endoplasmic reticulum in the hepatocyte. Lancet 2: 355–359, 1969.PubMedCrossRefGoogle Scholar
  28. 28.
    MAKINO I, SJOVALL J, NORMAN A, et al: Excretion of 3ß-hydroxy-5-cholanoic and 3hydroxy-5cholanoic acids in urine of infants with biliary atresia. FEBS Letters15: 161–164, 1971.PubMedCrossRefGoogle Scholar
  29. 29.
    BACK P: Identification and quantitative determination of urinary bile acids excreted in cholestasis. Clin Chilli Acta 44: 199–207, 1973.CrossRefGoogle Scholar
  30. 30.
    HUTTERER F, BACCHIN PG, RAISFELD IH, et al: Alteration of microsomal biotransformation in the liver in cholestasis. Proc Soc Exp Biol Med 133: 702–706, 1970.PubMedGoogle Scholar
  31. 31.
    FISHER MM, MAGNUSSON R, MIYAI K: Bile acid metabolism in mammals. I. Bile acid-induced intrahepatic cholestasis. Lab Invest 25: 88–91, 1971.PubMedGoogle Scholar
  32. 32.
    HUTTERER F, DENK H, BACCHIN PG, et al: Mechanism of cholestasis. I. Effect of bile acids on microsomal cytochrome P-450 dependent biotransformation system in vitro. Life Sci 9: 877–887, 1970.CrossRefGoogle Scholar
  33. 33.
    GREIM H, TRULZSCH D, ROBOZ J, et al: Mechanism of cholestasis. 5. Bile acids in normal rat livers and in those after bile duct ligation. Gastroenterology 63: 837–845, 1972.PubMedGoogle Scholar
  34. 34.
    GREIM H, TRULZSCH D, CZYGAN P, et al: Mechanism of cholestasis. 6. Bile acids in human livers with or without biliary obstruction. Gastroenterology 63: 846–850, 1972.PubMedGoogle Scholar
  35. 35.
    SCHAFFNER F, BACCHIN PG, HUTTERER F, et al: Mechanism of cholestasis. 4. Structural and biochemical changes in the liver and serum in rats after bile duct ligation. Gastroenterology 60: 888–897, 1971.PubMedGoogle Scholar
  36. 36.
    DENK H, GREIM H, HUTTERER F, et al: Turnover of hepatic cytochrome P-450 in experimental cholestasis. Exp Mol Pathol 19: 241–247, 1973.PubMedCrossRefGoogle Scholar
  37. 37.
    MACKINNON AM, SIMON FR: Reduced synthesis of hepatic microsomal cytochrome P-450 in the bile duct ligated rat. Biochem Biophys Res Commun 56: 437–443, 1974.PubMedCrossRefGoogle Scholar
  38. 38.
    POPPER H, SCHAFFNER F: Pathophysiology of cholestasis. Hum Pathol 1: 1–24, 1970.PubMedCrossRefGoogle Scholar
  39. 39.
    SCHERSTEN T: Metabolic differences between hepatitis and cholestasis in human liver. In Progress in Liver Diseases, vol. 4. Ed. H. Popper, F. Schaffner. New York, Grune and Stratton, 1972. pp. 133–150.Google Scholar
  40. 40.
    SEIDEL D, ALAUPOVIC P, FURMAN RH: A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects. J Clin Invest 48: 1211–1223, 1969.PubMedCrossRefGoogle Scholar
  41. 41.
    HARRY DS, DINI M, McINTYRE N: Effect of cholesterol feeding and biliary obstruction on hepatic cholesterol biosynthesis in the rat. Biochim Biophys Acta 296: 209–220, 1973.PubMedCrossRefGoogle Scholar
  42. 42.
    KATTERMAN R, CREUTZFELDT W: The effect of experimental cholestasis on the negative feedback regulation of cholesterol in rat liver. Scand J Gastroenterol 5: 337–342, 1970.Google Scholar
  43. 43.
    WEIS JH, DIETSCHY JM: Presence of an intact cholesterol feedback mechanism in the liver in biliary stasis. Gastroenterology 61; 77–84, 1971.PubMedGoogle Scholar
  44. 44.
    CARRUTHERS JS, STEINER JW: Experimental extrahepatic biliary obstruction: fine structural changes of liver cell mitochondria. Gastroenterology 42: 419–430, 1962.PubMedGoogle Scholar
  45. 45.
    KILLENBERG PG, HOPPEL CL: Inhibition of rat liver mitochondrial oxidative phosphorylation by sulfobromophthalein. Mol Pharmacol 10: 108–118, 1974.PubMedGoogle Scholar
  46. 46.
    OZAWA K, TAKASAN H, KITAMURA O, et al: Alteration in liver mitochondrial metabolism in a patient with biliary obstruction due to liver carcinoma. Am J Surg 126: 653–657, 1973.PubMedCrossRefGoogle Scholar
  47. 47.
    LEE MJ, WHITEHOUSE MW: Inhibition of electron transport and coupled phosphorylation in liver mitochondria by cholanic (bile) acids and their conjugates. Biochim Biophys Acta 100: 317–328, 1965.PubMedCrossRefGoogle Scholar
  48. 48.
    WITZLEBEN CL: Hepatic ultrastructural effects of cholic acid overload. Exp Mol Pathol 16: 47–53, 1972.PubMedCrossRefGoogle Scholar
  49. 49.
    KYAI K, PRICE VM, FISHER MM: Bile acid metabolism in mammals. Ultrastructural studies on the intrahepatic cholestasis induced by lithocholic and chenodeoxycholic acids in the rat. Lab Invest 24: 292–302, 1971.Google Scholar
  50. 50.
    BOYCE W, WITZLEBEN CL: Bilirubin as a cholestatic agent. II.Effect of variable doses of bilirubin on the severity of mangane sebilirubin cholestasis. Am J Pathol 72: 427–431, 1973.PubMedGoogle Scholar
  51. 51.
    FULOP M, KATZ S, LAWRENCE C: Extreme hyperbilirubinemia. Arch Int Med 127: 254–258, 1971.CrossRefGoogle Scholar
  52. 52.
    MULDER GJ: The rate limiting step in the biliary elimination of some substrates of uridine diphosphate glucuronyl transferase in the rat. Biochem Pharmacol 22: 1751–1763, 1973.PubMedCrossRefGoogle Scholar
  53. 53.
    ALPERT S, MOSHER M, SHANSKE A et al: Multiplicity of hepatic excretory mechanisms for organic anions. J Gen Physiol 53: 238–247, 1969.PubMedCrossRefGoogle Scholar
  54. 54.
    SIMON FR, ARIAS IM: Alteration of bile canalicular enzymes in cholestasis. A possible cause of bile secretory failure. J Clin Invest 52: 765–775, 1973.PubMedCrossRefGoogle Scholar
  55. 55.
    ESSNER E, NOVIKOFF A, MASEK B: Adenosinetriphosphatase activities in the plasma membrane of liver cells as revealed by electron microscopy. J Biochem Biophys Cytol 4: 711–716, 1958.CrossRefGoogle Scholar
  56. 56.
    SANDSTROM B: The functional significance of bile canalicular nucleoside phosphatase activity. Histochemie 25: 9–14, 1971.PubMedCrossRefGoogle Scholar
  57. 57.
    HOLZNER J: Fermenthistochemische Untersuchungen au Leberbiopsien. Verh Dtsch Ged Pathol 44: 233–237, 1960.Google Scholar
  58. 58.
    ERLINGER S, DHUMEAUX D: Mechanisms and control of secretion of bile water and electrolytes. Gastroenterology 66: 281–304, 1974.PubMedGoogle Scholar
  59. 59.
    DUMONT M, ERLINGER S: Influence of hydrocortisone on bile formation in the rat. Biol Gastroenterol (Paris) 6: 197–203, 1973.Google Scholar
  60. 60.
    SPERBER I: Biliary secretion of organic anions and its influence on bile flow. In The Biliary System. A Symposium of the NATO Advanced Study Institute. Ed. W. Taylor, Philadelphia, F.A. Davis, 1965. pp. 457–467.Google Scholar
  61. 61.
    SIMON FR, ARIAS IM: Alterations in liver plasma membranes and their possible role in cholestasis. Gastroenterology62: 342–345, 1972.PubMedGoogle Scholar
  62. 62.
    JAVITT NB: The cholestatic syndrome -1971. Am J Med 51: 637–641, 1971.PubMedCrossRefGoogle Scholar
  63. 63.
    HERNDON JH Jr: Pathophysiology of pruritus associated with elevated bile acids in serum. Arch Intern Med 130: 632–637, 1972.CrossRefGoogle Scholar
  64. 64.
    MIYAI K, MAYR W, RICHARDSON A: Freeze fracture study of bile canalicular changes induced by lithocholic acid. Lab Invest 30: 384, 1974.Google Scholar
  65. 65.
    COOPER AD, JONES AL, KOLDINGER RE, et al: Selective biliary obstruction: a model for the study of lipid metabolism in cholestasis. Gastroenterology 66: 574–585, 1974.PubMedGoogle Scholar
  66. 66.
    CLAUDE A: Growth and differentiation of cytoplasmic membranes in the course of lipoprotein granule synthesis in the hepatic cell. I.Elaboration of elements of the Golgi complex. J Cell Biol 47: 745–766, 1970.PubMedCrossRefGoogle Scholar
  67. 67.
    STEIN O, BAR-ON H, STEIN Y: Lipoproteins and the liver. In Progress in Liver Diseases, vol. 4. Ed. H. Popper, F. Schaffner. New York, Grune and Stratton, 1972. pp. 45–62.Google Scholar
  68. 68.
    REYES H, LEVI AJ, GATMAITAN Z, et al: Studies of Y and Z, two hepatic cytoplasmic anion-binding proteins: effect of drugs, chemicals, hormones, and cholestasis. J Clin Invest 50: 2242–2252, 1971.PubMedCrossRefGoogle Scholar
  69. 69.
    ’STEINER JW, CARRUTHERS JS: Experimental extrahepatic biliary obstruction. Some aspects of the fine sturctural changes of bile ductules and pre-ductules (Ducts of Hering). Am J Pathol 40: 253–270, 1962.PubMedGoogle Scholar
  70. 70.
    SASAKI H, SCHAFFNER F, POPPER H: Bile ductules in cholestasis. Morphologic evidence for secretion and absorption in man. Lab Invest 16: 84–95, 1967.PubMedGoogle Scholar
  71. 71.
    SCHAFFNER F, POPPER H: Electron microscopic studies of normal and proliferated bile ductules. Am J Pathol 38: 393–410, 1961.PubMedGoogle Scholar
  72. 72.
    STEINER JW, CARRUTHERS JS, KALIFAT SR: The ductular cell reaction of rat liver in extrahepatic cholestasis. I. Proliferated biliary epithelial cells. Exp Md. Pathol 1; 162–185, 1962.CrossRefGoogle Scholar
  73. 73.
    GUZELIAN P, BOYER JL: Glucose reabsorption from bile. Evidence for a biliohepatic circulation. J Clin Invest 53: 526–535, 1974.PubMedCrossRefGoogle Scholar
  74. 74.
    SCHAFFNER F, SCHARNBECK HH, HUTTERER F, et al: Mechanism of cholestasis. VII: naphthylisothiocyanate induced jaundice. Lab Invest 28: 321–331, 1973.PubMedGoogle Scholar
  75. 75.
    KLION FM, SCHAFFNER F: Electron microscopic observations in primary biliary cirrhosis. Arch Pathol (Chicago) 81: 152–161, 1966.PubMedGoogle Scholar
  76. 76.
    HUNT R, LEVEILLE G, SAUBERLICH H: Dietary bile acids and lipid metabolism. Effects of lithocholic acid in mammalian species. Proc Soc Exp Biol Med 115: 277–280, 1964.PubMedGoogle Scholar
  77. 77.
    PALMER RH, HRUBAN Z: Production of bile duct hyperplasia and gallstones by lithocholic acid. J Clin Invest 45: 1255–1267, 1966.PubMedCrossRefGoogle Scholar
  78. 78.
    BIAVA C: Studies on cholestasis. The fine structure and morphogenesis of hepatocellular and canalicular bile pigment. Lab Invest 13: 1099–1123, 1964.PubMedGoogle Scholar
  79. 79.
    HOLLANDER M, SCHAFFNER F: Electron microscopic studies in biliary atresia. I. Bile ductular proliferation. Am J Pis Child 116: 49–56, 1968.Google Scholar
  80. 80.
    GERBER MA, ORR W, DENK H, et al: Hepatocellular hyalin in cholestasis and cirrhosis: its diagnostic significance. Gastroenterology 64: 89–98, 1973.PubMedGoogle Scholar
  81. 81.
    JAVITT NB, MORRISSEY KP, SIEGEL E, et al: Cholestatic syndromes in infancy: diagnostic value of serum bile acid pattern and cholestyramine administration. Pediatr. Res 7: 119–125, 1973.PubMedCrossRefGoogle Scholar
  82. 82.
    SHARP HL, MIRKIN BL: Effect of phenobarbital on hyperbilirubinemia, bile acid metabolism and microsomal enzyme activity in chronic intrahepatic cholestasis of childhood. J Pediatr 81; 116–126, 1972.PubMedCrossRefGoogle Scholar
  83. 83.
    BRAUN W, WOCKEL W, GIERTLER U, et al: Phenobarbital behandlung der benignen rezidivierenden intrahepatischen Cholestase. Schweiz Med Wochensc 102: 1769–1772, 1972.Google Scholar
  84. 84.
    STIEHL A, THALER MM, ADMIRAND WH: Effects of phenobarbital on bile salt metabolism in cholestasis due to bile duct hypoplasia. Pediatrics 51: 992–997, 1973.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1975

Authors and Affiliations

  • Fenton Schaffner
    • 1
  • Hans Popper
    • 1
  1. 1.Stratton Laboratory for Liver Diseases, Mount Sinai School of MedicineThe City University of New YorkNew YorkUSA

Personalised recommendations